Reports for METHYLPHENIDATE HYDROCHLORIDE
Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-09-30 | 2022-10-22 | 170536 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-12-02 | 2023-01-09 | 176978 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-02-03 | 2023-02-17 | 183533 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-04-05 | 2023-04-19 | 188877 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Avoided shortage | 2023-06-28 | 2023-06-28 | 196767 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-07-21 | 2023-08-28 | 199441 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-09-07 | 2023-09-23 | 203858 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RITALIN 10MG | 10MG | TABLET | Discontinued | 2022-02-08 | 2022-05-11 | 154449 |
| METHYLPHENIDATE | 10MG | TABLET | Discontinued | 2019-04-10 | 2019-04-11 | 81136 |
| PMS-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-06-17 | 2020-06-17 | 118105 |
| RITALIN-SR TAB 20MG | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-02-08 | 2022-04-05 | 154439 |
| RITALIN 20MG | 20MG | TABLET | Discontinued | 2019-07-22 | 2019-08-01 | 89771 |
| SANDOZ METHYLPHENIDATE SR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-05-24 | 2022-05-24 | 161221 |
| METHYLPHENIDATE | 20MG | TABLET | Discontinued | 2019-04-10 | 2019-04-11 | 81139 |
| PMS-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-06-17 | 2020-06-17 | 118099 |
| PMS-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-06-17 | 2020-06-17 | 118108 |
| PMS-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-06-17 | 2020-06-17 | 118102 |